Large-scale Whole-exome Sequencing Association Study Identifies FOXH1 Gene and Sphingolipid Metabolism Pathway Influencing Major Depressive Disorder
Overview
Pharmacology
Affiliations
In the present study, we performed an exome-wide investigation of the burden of rare disease-causing variants for major depressive disorder (MDD) using 16,702 samples from UK biobank. Gene-based association analysis and candidate gene prioritization analysis indicated that FOXH1 have significant association with MDD. In addition, sphingolipid metabolism pathway was found to be less enriched with rare disease-causing variants in the MDD group, suggesting that this gene set may be involved in the pathophysiology of MDD.
Perez-Gutierrez A, Carmona R, Loucera C, Cervilla J, Gutierrez B, Molina E Mol Psychiatry. 2024; 29(11):3553-3566.
PMID: 38806690 DOI: 10.1038/s41380-024-02609-2.
Oh E, Han K, Kim A, Kang Y, Tae W, Han M Transl Psychiatry. 2024; 14(1):141.
PMID: 38461185 PMC: 10924915. DOI: 10.1038/s41398-024-02849-4.
Xu H, Li T, Gong Q, Xu H, Hu Y, Lu W Front Neurol. 2023; 14:1153509.
PMID: 37168668 PMC: 10165312. DOI: 10.3389/fneur.2023.1153509.
Kamran M, Bibi F, Rehman A, Morris D Genes (Basel). 2022; 13(4).
PMID: 35456452 PMC: 9025468. DOI: 10.3390/genes13040646.
Identification of putative genetic variants in major depressive disorder patients in Pakistan.
Qazi S, Irfan M, Ramzan Z, Jahanzaib M, Zaman Khan M, Nasir M Mol Biol Rep. 2022; 49(3):2283-2292.
PMID: 35040003 DOI: 10.1007/s11033-021-07050-0.